FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386882003: Dornase alfa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461060014 Dornase alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1480996013 Dornase alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59291000195117 dornase alfa it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
34961000188111 dornase alpha fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74591000195118 Dornase alfa de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dornase alfa (substance) Is a agent mucolytique false Inferred relationship Some
Dornase alfa (substance) Is a Esterase true Inferred relationship Some
Dornase alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) true Inferred relationship Some
Dornase alfa (substance) Is a Respiratory system agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing dornase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dornase alfa (substance) Inferred relationship Some 1
Dornase alfa adverse reaction Causative agent (attribute) True Dornase alfa (substance) Inferred relationship Some 1
Allergy to dornase alfa (finding) Causative agent (attribute) False Dornase alfa (substance) Inferred relationship Some
Dornase alfa 2500units(2.5mg) nebulizer solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dornase alfa (substance) Inferred relationship Some
Allergy to dornase alfa (finding) Causative agent (attribute) True Dornase alfa (substance) Inferred relationship Some 1
Product containing only dornase alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dornase alfa (substance) Inferred relationship Some 1
Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dornase alfa (substance) Inferred relationship Some 1
Product containing precisely dornase alfa 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Dornase alfa (substance) Inferred relationship Some 1
Product containing dornase alfa in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dornase alfa (substance) Inferred relationship Some 1
Dornase alfa only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dornase alfa (substance) Inferred relationship Some 1
Dornase alfa 1 mg/mL solution for nebuliser The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dornase alfa (substance) Inferred relationship Some 1
Dornase alfa 1 mg/mL solution for nebuliser This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dornase alfa (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start